12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]

RxCUI
860738
RxNorm name
12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]
Display name
12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]
Full name
12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e038f963-d78f-460e-a11f-46f224061505Ranexa 500 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa] [SBD] · Ranexa 500 MG 12 HR Extended Release Oral Tablet [SY]33These highlights do not include all the information needed to use RANEXA safely and effectively. See full prescribing information for RANEXA. RANEXA ® (ranolazine) extended-release tablets, for oral use Initial U.S. Approval: 200620160806
8d442b8c-97a8-40a9-8603-f9cd0542cedcRanexa 500 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa] [SBD] · Ranexa 500 MG 12 HR Extended Release Oral Tablet [SY]32These highlights do not include all the information needed to use Ranexa safely and effectively. See full prescribing information for Ranexa. Ranexa (ranolazine) extended-release tablets Initial U.S. Approval: 200620100426